Skip to content
Study at a glance
AI-extracted from the abstract
| Characteristics |
Theoretical or philosophical paper
Peer reviewed
|
| Intervention |
3-Cycloaminoindole compounds
|
| Topics |
Serotonin
|
| Key points |
Proposes that novel 3-cycloaminoindole compounds act as serotonergic psychedelic agents for treating psychosis, mental illness, and CNS disorders. |
Abstract
Novel 3-Cycloaminoindole Compounds as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.
Related reading
-
Novel Indazole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.
ACS Med Chem Lett
June 10, 2025
-
Novel N‑Substituted Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.
ACS Med Chem Lett
June 16, 2025
-
Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.
ACS Medicinal Chemistry Letters
June 12, 2025
4 citations
-
Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress Disorder.
ACS Medicinal Chemistry Letters
January 9, 2025
7 citations
-
Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders.
ACS Med Chem Lett
April 27, 2026